Teva licenses glatiramer acetate to Takeda in Japan

A board to discuss the Multiple Sclerosis modifying drug Copaxone

Teva licenses glatiramer acetate to Takeda in Japan

Postby MSUK » Fri Dec 06, 2013 5:28 am

Teva Pharmaceutical has licensed rights to commercialize glatiramer acetate to Takeda Pharmaceutical in Japan as part of their agreement signed earlier in 2013.<br><br>

Currently both the firms are working on additional agreements for implementation of the license..... Read More - http://www.ms-uk.org/copaxone
MS-UK - http://www.ms-uk.org/
User avatar
MSUK
Family Elder
 
Posts: 2176
Joined: Wed Oct 14, 2009 3:00 pm

Advertisement

Re: Teva licenses glatiramer acetate to Takeda in Japan

Postby NHE » Fri Dec 06, 2013 5:55 am

Under the deal, Teva will grant Takeda commercialization rights in Japan, and Takeda will submit a New Drug Application (NDA) for registration of glatiramer acetate in Japan.

This sounds like a way for Teva to potentially extend their patent vicariously through Takeda and then collect license fees for the duration of Takeda's production of Copaxone.
User avatar
NHE
Volunteer Moderator
 
Posts: 3355
Joined: Sat Nov 20, 2004 4:00 pm


Return to Copaxone

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service